These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26040994)

  • 1. Angelman Syndrome.
    Margolis SS; Sell GL; Zbinden MA; Bird LM
    Neurotherapeutics; 2015 Jul; 12(3):641-50. PubMed ID: 26040994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angelman syndrome - insights into a rare neurogenetic disorder.
    Buiting K; Williams C; Horsthemke B
    Nat Rev Neurol; 2016 Oct; 12(10):584-93. PubMed ID: 27615419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3.
    Jiang YH; Pan Y; Zhu L; Landa L; Yoo J; Spencer C; Lorenzo I; Brilliant M; Noebels J; Beaudet AL
    PLoS One; 2010 Aug; 5(8):e12278. PubMed ID: 20808828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From pathogenesis to treatment of genetic intellectual disabilities: a lesson from Angelman syndrome research].
    Saitoh S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Jun; 33(3):127-30. PubMed ID: 25069246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-Phenotype Correlations in Angelman Syndrome.
    Yang L; Shu X; Mao S; Wang Y; Du X; Zou C
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34203304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angelman syndrome and severe infections in a patient with de novo 15q11.2-q13.1 deletion and maternally inherited 2q21.3 microdeletion.
    Neubert G; von Au K; Drossel K; Tzschach A; Horn D; Nickel R; Kaindl AM
    Gene; 2013 Jan; 512(2):453-5. PubMed ID: 23124039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
    Samaco RC; Hogart A; LaSalle JM
    Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing spine issues: If offers novel therapeutics to Angelman syndrome.
    Yang X
    Dev Neurobiol; 2020 May; 80(5-6):200-209. PubMed ID: 32378784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epigenetics of Angelman syndrome.
    Lalande M; Calciano MA
    Cell Mol Life Sci; 2007 Apr; 64(7-8):947-60. PubMed ID: 17347796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the pathogenesis of Angelman syndrome through animal models.
    Jana NR
    Neural Plast; 2012; 2012():710943. PubMed ID: 22830052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2-q13.3 duplication syndrome.
    Copping NA; Christian SGB; Ritter DJ; Islam MS; Buscher N; Zolkowska D; Pride MC; Berg EL; LaSalle JM; Ellegood J; Lerch JP; Reiter LT; Silverman JL; Dindot SV
    Hum Mol Genet; 2017 Oct; 26(20):3995-4010. PubMed ID: 29016856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult
    Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
    J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome.
    Mulherkar SA; Jana NR
    Neurobiol Dis; 2010 Dec; 40(3):586-92. PubMed ID: 20696245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.
    Geerts-Haages A; Bossuyt SNV; den Besten I; Bruggenwirth H; van der Burgt I; Yntema HG; Punt AM; Brooks A; Elgersma Y; Distel B; Valstar M
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1481. PubMed ID: 32889787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
    Dodge A; Peters MM; Greene HE; Dietrick C; Botelho R; Chung D; Willman J; Nenninger AW; Ciarlone S; Kamath SG; Houdek P; Sumová A; Anderson AE; Dindot SV; Berg EL; O'Geen H; Segal DJ; Silverman JL; Weeber EJ; Nash KR
    Autism Res; 2020 Mar; 13(3):397-409. PubMed ID: 31961493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersociability in the Angelman syndrome mouse model.
    Stoppel DC; Anderson MP
    Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards an understanding of Angelman syndrome in mice studies.
    Yang X
    J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.
    Miura K; Kishino T; Li E; Webber H; Dikkes P; Holmes GL; Wagstaff J
    Neurobiol Dis; 2002 Mar; 9(2):149-59. PubMed ID: 11895368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.